Plain-English translation of NCT06679920 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bladder Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new imaging device called optical coherence tomography (OCT) that uses infrared light to take very detailed pictures of bladder tissue during bladder cancer surgery. The goal is to help doctors see cancerous areas more clearly and make better treatment decisions, potentially avoiding the need for repeat surgeries.
Currently, bladder cancer patients often need multiple surgeries and procedures to confirm the extent of their cancer. This new imaging technology could help doctors get better information during the first surgery, reducing the burden on patients and the number of procedures they need.
You likely qualify if…
You likely don't qualify if…
If you qualify, the new imaging device will be used during your standard bladder cancer surgery (transurethral resection). The OCT probe will take detailed pictures of your bladder tissue to help your doctor evaluate the cancer more thoroughly. This is done as part of your regular surgical procedure, and the study involves 15 patients total.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Netherlands
Sponsor
Amsterdam UMC
Enrollment target
~15 participants
Started
December 2024
Primary completion
March 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Marinka Remmelink, MD
Amsterdam UMC
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.